ESC Premium Access

Determinants of left ventricular ATP availability measured in vivo and ex vivo in patients with severe aortic stenosis: correlation of creatine kinase activity with LVEF and ATP diffusion distance

Congress Presentation

About the speaker

Doctor Mark Andrew Peterzan

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Clinical characteristics and outcomes after TAVI in patients reclassified to moderate aortic stenosis by integration of multimodality imaging and pressure recovery

Speaker: Doctor E. Holy (Zurich, CH)


Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.

Speaker: Doctor A. Guha (Augusta, US)


Predictors of short- and mid-term outcomes after TAVR in low-flow, low-gradient aortic stenosis

Speaker: Doctor V. Emer Egypto Rosa (Sao Paulo, BR)


Single-center experience with different regimes of antiplatelet therapy and oral anticoagulation in transcatheter aortic valve replacement

Speaker: Doctor V. Veulemans (Duesseldorf, DE)


Left-sided deviation and fibrous-fatty infiltration of the right bundle branch in the elderly: implication for transcatheter aortic valve implantation (TAVI) procedure

Speaker: Professor J. Cabrera (Pozuelo de Alarcon, Madrid, ES)


Access the full session

Aortic valve replacement: diagnostic and treatment considerations

Speakers: Doctor M. Peterzan, Doctor E. Holy, Doctor A. Guha, Doctor V. Emer Egypto Rosa, Doctor V. Veulemans...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by